Pharma OTC industry meeting in Munich

München, 16. November 2018. Der in München ansässige Spezialist für CRM im Pharmabereich ysura GmbH eröffnete eine neue Reihe des etablierten Veranstaltungsformats „Vitamin C“ mit dem Fokus auf OTC. Bei dem Branchentreffen in München wurden in Vorträgen und Diskussionen wichtige Sales- und Marketingthemen für die Digitalisierung des „Over The Counter“ genannten Bereichs erörtert.



Multichannel in pharmacies - reality or wishful thinking?

Philip Debbas, CEO ysura

"The pharmacy is increasingly transforming itself into a healthcare provider. Therefore, pharmaceutical companies must find intelligent answers to the digital change in pharmacies," said Philip Debbas, CEO of ysura GmbH and organizer of the "Vitamin C" series. The key to success remains personal contact.




Digital marketing at the Point of Care

Christian Senger, General Manager intermedix


This also raises the question of how healthcare IT can be used as a communication platform. Because studies show: The majority of doctors cannot find the information they need on the Internet. "Information must be placed where doctors and pharmacists can find it, namely in their own software. Only in this way is effective digital marketing possible," said Christian Senger, General Manager of intermedix Deutschland GmbH, in his presentation. The improved communication at the point of care, i.e. when pharmacist and patient meet, leads to significantly higher additional charges. His tip for those responsible in the sales force: "Get involved with the prescription and delivery process, because they are the pivotal points of pharmaceutical communication



More data - less knowledge

Alexander Wittke, Geschäftsführer Saletelligence


Another important topic that concerns the OTC specialists is data. In the course of digitization, pharmaceutical companies are collecting an exponentially increasing amount of data. The participants in the discussion round agree that they are the oil of this century. The problem is: "There is still less knowledge about the customer. Therefore, in the future it will be a matter of converting the data into valuable information for the company, namely those that interest the pharmacist," Alexander Wittke, Managing Director of Saletelligence, explains in his presentation.